1. Home
  2. TNGX vs IRBT Comparison

TNGX vs IRBT Comparison

Compare TNGX & IRBT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TNGX
  • IRBT
  • Stock Information
  • Founded
  • TNGX 2014
  • IRBT 1990
  • Country
  • TNGX United States
  • IRBT United States
  • Employees
  • TNGX N/A
  • IRBT N/A
  • Industry
  • TNGX Biotechnology: Pharmaceutical Preparations
  • IRBT Consumer Electronics/Appliances
  • Sector
  • TNGX Health Care
  • IRBT Consumer Discretionary
  • Exchange
  • TNGX Nasdaq
  • IRBT Nasdaq
  • Market Cap
  • TNGX 317.4M
  • IRBT 257.3M
  • IPO Year
  • TNGX N/A
  • IRBT N/A
  • Fundamental
  • Price
  • TNGX $1.37
  • IRBT $2.75
  • Analyst Decision
  • TNGX Strong Buy
  • IRBT Hold
  • Analyst Count
  • TNGX 7
  • IRBT 1
  • Target Price
  • TNGX $12.33
  • IRBT N/A
  • AVG Volume (30 Days)
  • TNGX 789.1K
  • IRBT 3.1M
  • Earning Date
  • TNGX 05-07-2025
  • IRBT 03-12-2025
  • Dividend Yield
  • TNGX N/A
  • IRBT N/A
  • EPS Growth
  • TNGX N/A
  • IRBT N/A
  • EPS
  • TNGX N/A
  • IRBT N/A
  • Revenue
  • TNGX $42,069,000.00
  • IRBT $681,849,000.00
  • Revenue This Year
  • TNGX N/A
  • IRBT $10.11
  • Revenue Next Year
  • TNGX N/A
  • IRBT $20.85
  • P/E Ratio
  • TNGX N/A
  • IRBT N/A
  • Revenue Growth
  • TNGX 15.17
  • IRBT N/A
  • 52 Week Low
  • TNGX $1.33
  • IRBT $2.60
  • 52 Week High
  • TNGX $12.02
  • IRBT $14.51
  • Technical
  • Relative Strength Index (RSI)
  • TNGX 26.22
  • IRBT 26.69
  • Support Level
  • TNGX $1.48
  • IRBT $3.04
  • Resistance Level
  • TNGX $1.66
  • IRBT $3.39
  • Average True Range (ATR)
  • TNGX 0.16
  • IRBT 0.41
  • MACD
  • TNGX -0.01
  • IRBT -0.00
  • Stochastic Oscillator
  • TNGX 5.63
  • IRBT 11.41

About TNGX Tango Therapeutics Inc.

Tango Therapeutics Inc is a biotechnology company. It is dedicated towards discovering novel drug targets and delivering the next generation of precision medicine for the treatment of cancer. It is engaged in the business of discovering and developing precision oncology therapies. Its program TNG908, is an MTA-cooperative inhibitor of PRMT5 designed to work selectively in cancer cells with an MTAP deletion. Its pipeline further consists of discovery programs such as, TNG462, TNG348, TNG260 and others for multiple cancer types with limited treatment options.

About IRBT iRobot Corporation

iRobot Corp is a united state based consumer robot company. It designs and builds robots that assist consumers with the solutions for the activities to be carried both inside and outside of the home. The company's consumer robot comprises a portfolio of solutions which includes cleaning, mapping and navigation, human-robot interaction, and physical solutions. The company operates in the business segment of Consumer robots. The consumer robot products are provided to the consumers by retail businesses and online store. The company derives its revenue from the product sales. It sells the products across the United States and around the world.

Share on Social Networks: